LONDON — The chair of Britain’s coronavirus vaccine task force says data evaluating the efficacy and safety of the two most advanced candidates should be available in early December.
Kate Bingham told a Parliamentary committee on Wednesday that data on the two vaccine candidates — developed by Oxford University and AstraZeneca and Pfizer and BioNTech — should be available by then.
After that, the vaccine candidates will need regulatory approval.
Stay connected to the stories and events that make your community a special place to call home.
Subscriptions start at $14.90/month.View subscription options
- Unmatched coverage of Allen County’s local news and sports, a tradition dating back to 1867
- Compelling portraits of our residents, experienced reporting and thoughtful analysis
- Unlimited online access to iolaregister.com and our archives